P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma

Hemasphere · 2022 · PMC9621536

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

Conclusion: There was a numerical trend towards better CR and EFS for novel therapy compared to traditional chemotherapy for first salvage, however the outcomes were not statistically significant, demonstrating that chemotherapy is still a valid option for salvage before ASCT.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.